Benzinga | Sep 3, 2021 06:47AM EDT

UBS Maintains Buy on DocuSign, Raises Price Target to $350

UBS analyst Karl Keirstead maintains DocuSign (NASDAQ:DOCU) with a Buy and raises the price target from $340 to $350.